See more : PT Nusatama Berkah Tbk (NTBK.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Spectral AI, Inc. (MDAI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Spectral AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Affinity Bancshares, Inc. (AFBI) Income Statement Analysis – Financial Results
- First Bank (FRBA) Income Statement Analysis – Financial Results
- ETS Group Limited (8031.HK) Income Statement Analysis – Financial Results
- Crunchfish AB (publ) (CFISH.ST) Income Statement Analysis – Financial Results
- Lloyd Fonds AG (L1OA.DE) Income Statement Analysis – Financial Results
Spectral AI, Inc. (MDAI)
About Spectral AI, Inc.
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 18.06M | 25.37M | 15.24M |
| Cost of Revenue | 10.18M | 14.53M | 8.19M |
| Gross Profit | 7.88M | 10.84M | 7.05M |
| Gross Profit Ratio | 43.64% | 42.72% | 46.28% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 20.86M | 13.48M | 11.23M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 20.86M | 13.48M | 11.23M |
| Other Expenses | 0.00 | 49.00K | 0.00 |
| Operating Expenses | 20.86M | 13.48M | 11.23M |
| Cost & Expenses | 31.04M | 28.02M | 19.42M |
| Interest Income | 172.00K | 21.00K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 722.00K | 568.00K | 1.00K |
| EBITDA | -12.26M | -2.08M | -4.18M |
| EBITDA Ratio | -67.91% | -7.42% | -28.14% |
| Operating Income | -12.98M | -2.65M | -4.18M |
| Operating Income Ratio | -71.91% | -10.43% | -27.42% |
| Total Other Income/Expenses | -7.86M | -159.00K | 93.00K |
| Income Before Tax | -20.84M | -2.81M | -4.09M |
| Income Before Tax Ratio | -115.44% | -11.06% | -26.81% |
| Income Tax Expense | 11.00K | 106.00K | -98.00K |
| Net Income | -20.85M | -2.91M | -3.99M |
| Net Income Ratio | -115.50% | -11.48% | -26.17% |
| EPS | -1.48 | -0.16 | -0.22 |
| EPS Diluted | -1.48 | -0.16 | -0.22 |
| Weighted Avg Shares Out | 14.09M | 17.88M | 17.88M |
| Weighted Avg Shares Out (Dil) | 14.09M | 17.88M | 17.88M |
American Burn Association Study Highlights Inequities in Access to Specialized Burn Care
Spectral AI's DeepView® System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare Resources Spectral AI's DeepView® System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare Resources
Spectral AI secures government funding to advance battlefield wound assessment device
Spectral AI Inc (NASDAQ:MDAI) announced that it has been awarded more than $850,000 from the Medical Technology Enterprise Consortium (MTEC), a biomedical group collaborating with the US Army Medical Material Development Activity, to support the ongoing development of its DeepView SnapShot...
Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®
DALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it...
Spectral AI to Participate in Upcoming Investor Conferences
DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Peter...
Spectral AI completes burn center enrollment early for pivotal study
Spectral AI Inc (NASDAQ:MDAI) announced that it has completed the enrollment of adult and pediatric patients at US burn centers for its pivotal study designed to validate the AI algorithm used by its DeepView system for the burn indication. The...
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
Milestone Achievement Advances Commercialization Timeline for DeepView™ System for Burn Indication Milestone Achievement Advances Commercialization Timeline for DeepView™ System for Burn Indication
Spectral AI to present data from ongoing pivotal burn study at conference
Spectral AI Inc (NASDAQ:MDAI) announced that its chief medical consultant Dr Jeffrey Carter will present data from its ongoing multicenter study evaluating its DeepView System for burns at an upcoming conference. The DeepView System leverages non-invasive multispectral imaging technology and proprietary...
Spectral AI Announces Podium Presentation at BBA / ISBI Joint Conference Assessing Burn Wound Severity Using Multispectral Imaging and Artificial Intelligence
DALLAS, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Dr....
Spectral AI, Inc. (MDAI) Q2 2024 Earnings Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI ) Q2 2024 Results Conference Call August 12, 2024 5:00 PM ET Company Participants Devin Sullivan - Managing Director, The Equity Group, Inc. Peter Carlson - Chief Executive Officer Vince Capone - Chief Financial Officer Jeremiah...
Spectral AI grows revenue, advances DeepView System for burns in Q2
Spectral AI Inc (NASDAQ:MDAI) reported a 76% year-over-year jump in revenue for the second quarter as it advanced its AI-driven DeepView System for the burn indication. The company said its Q2 research and development revenue was $7.5 million up from...
Source: https://incomestatements.info
Category: Stock Reports